Dynamic42
Germany
aliveseries-a
series-a
Stage
1
Investors
About
Dynamic42 develops and produces microphysiological in vitro systems (organ-on-chip systems) for drug development and personalized medicine. These systems simulate human organs on a microchip for more precise and efficient testing of active ingredients and therapies.
Explore Dynamic42's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.